JUNB and neoplasm: Interestingly, a shift in the AP1 complex composition from c-Jun/Fra-1 to c-Jun/c-Fos heterodimers has been observed during tumor progression [17,18] and c-Fos has been shown to be essential for malignant progression of skin tumors [19,20].